New insider activity at Verastem ( (VSTM) ) has taken place on November 6, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
President & CEO Dan Paterson has recently sold 1,299 shares of Verastem stock, amounting to a total transaction value of $12,145.
Recent Updates on VSTM stock
In the last 24 hours, Verastem Inc (VSTM) reported its Q3 2025 earnings, showcasing a strong commercial launch of its AVMAPKI FAKZYNJA CO-PACK with net product revenue of $11.2 million, surpassing expectations. Despite this, the stock experienced a decline due to the need for additional patient enrollment in the RAMP-301 trial and uncertainty regarding the inclusion of AVMAPKI FAKZYNJA in updated treatment guidelines. The company remains financially stable with $137.7 million in cash, supporting its operations into the second half of 2026. Verastem is advancing its clinical pipeline, particularly with its KRAS G12D inhibitor, VS-7375, and anticipates key data readouts in 2026. Analysts maintain a positive outlook, citing the company’s strategic focus and promising clinical advancements as reasons for optimism.
Spark’s Take on VSTM Stock
According to Spark, TipRanks’ AI Analyst, VSTM is a Neutral.
Verastem’s overall stock score is primarily impacted by its weak financial performance, characterized by ongoing losses and negative equity. However, positive technical indicators and recent corporate events, such as the $75M private placement, provide some optimism for future growth. Valuation remains constrained by negative earnings, but strategic initiatives and product development efforts could drive improvements. The stock represents a speculative opportunity, with potential upside if financial health and operational efficiencies improve.
To see Spark’s full report on VSTM stock, click here.
More about Verastem
YTD Price Performance: 25.73%
Average Trading Volume: 2,607,755
Technical Sentiment Signal: Buy
Current Market Cap: $528.2M